• CX-5461 Induces Mitotic Catastrophe in Cervical Cancer Cells

  2026-06-11

  The referenced study demonstrates that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell proliferation by inducing DNA damage and mitotic catastrophe, and sensitizes cells to cisplatin. These findings highlight a mechanistically distinct approach to overcoming chemoresistance and targeting ribosome biogenesis in solid tumors.

• Go 6983 (pan-PKC Inhibitor): Optimizing PKC Signaling Pathwa

  2026-06-11

  Go 6983 accelerates PKC signaling pathway research with unmatched potency, selectivity, and assay versatility. Discover how this pan-PKC inhibitor streamlines cancer progression studies, EMT assays, and cell fate analyses with reproducible, nanomolar-level inhibition.

• Bromodomain Inhibitor, (+)-JQ1: Protocols, Synergy & Trouble

  2026-06-10

  Bromodomain Inhibitor, (+)-JQ1 unlocks precise BET inhibition for oncology, inflammation, and male contraception workflows. Recent synergy data in pancreatic cancer and actionable troubleshooting tips empower reproducible, high-impact research.

• Annexin V-FITC/7-AAD Apoptosis Kit: Practical Workflow Guide

  2026-06-10

  The Annexin V-FITC/7-AAD Apoptosis Kit enables rapid and reliable discrimination between apoptotic and necrotic cells in standard cell death analysis workflows. It is best suited for fluorescence-based cell viability and cytotoxicity assays using flow cytometry or microscopy and should not be used for mechanistic pathway studies or non-standard cell types.

• Moxidectin Boosts Polyene Antifungal Activity via Ergosterol

  2026-06-09

  A 2024 study reveals that moxidectin, a macrocyclic lactone anthelmintic, significantly enhances the antifungal efficacy of polyenes against Candida albicans by elevating fungal ergosterol levels. This mechanism-driven synergy offers a promising new approach to oral candidiasis management, especially relevant amid rising drug resistance.

• Indomethacin in Inflammation Research: Protocols and Pitfall

  2026-06-09

  Indomethacin stands out as a nonsteroidal anti-inflammatory drug with unique utility in inflammation, lipid metabolism, and membrane signaling studies. This article delivers protocol-driven guidance, troubleshooting, and comparative insights, enabling researchers to optimize their experimental workflows with confidence.

• Sulfachloropyridazine in Antimicrobial Assays: Protocols & I

  2026-06-08

  Sulfachloropyridazine, a potent sulfonamide antibacterial agent, offers unique advantages for both mechanistic studies and microbiome modulation in infection models. This article translates the latest research into actionable workflows and troubleshooting strategies, making it indispensable for antimicrobial susceptibility testing and microbial ecology research.

• Plk1 Regulation of p31comet Controls Mitotic Checkpoint Disa

  2026-06-08

  This study elucidates how Polo-like kinase 1 (Plk1) regulates the mitotic checkpoint protein p31comet, directly impacting the disassembly of mitotic checkpoint complexes (MCC) and ensuring proper timing of anaphase. The findings clarify a key inhibitory phosphorylation event that prevents premature checkpoint inactivation, with implications for understanding chromosome segregation and targeting mitotic regulators in cancer research.

• Baicalein for Cancer & Inflammation: Protocols and Troublesh

  2026-06-07

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) is a high-purity flavonoid, uniquely positioned for targeted inhibition of the 12-LOX pathway in cancer and inflammation research. This article delivers actionable experimental workflows, troubleshooting insights, and practical protocol enhancements, leveraging recent advances and comparative studies to maximize reproducibility and translational value.

• Brinzolamide Nanoemulsions: Ocular Penetration and Excipient

  2026-06-06

  This study systematically evaluates brinzolamide-loaded nanoemulsions for ocular delivery, focusing on ex vivo corneal permeation and the safety profile of excipients. Notably, Triacetin emerges as a low-toxicity oil phase component suitable for ophthalmic formulations, supporting its expanding role in life science research.

• PBS Liposomes: Reliable Controls for Macrophage Depletion As

  2026-06-05

  This article explores the scientific rationale, practical workflows, and vendor reliability considerations for PBS Liposomes (SKU K2722) as gold-standard controls in macrophage depletion studies. Integrating scenario-driven laboratory challenges with evidence-based solutions, it demonstrates how PBS Liposomes ensure reproducible, interpretable results in cell viability and phagocytosis assays.

• LG 101506: RXR Modulator Unlocking Immune Regulation in Canc

  2026-06-05

  Explore how LG 101506, a potent RXR modulator, is revolutionizing RXR signaling pathway research and cancer immunology by bridging retinoid biology with immune checkpoint mechanisms. Uncover unique, practical insights for assay design and translational strategy.

• Eliminating Pollen Interference in Hazardous Substance Detec

  2026-06-04

  This study introduces a robust machine-learning approach to identify and remove pollen-induced spectral interference in excitation–emission matrix (EEM) fluorescence data for hazardous substance classification. The findings establish a validated workflow that significantly improves the accuracy and reliability of rapid bioaerosol detection, with broad implications for public health monitoring.

• Strategic Calpain Inhibition: Mechanistic Leverage for Trans

  2026-06-04

  This thought-leadership article dissects the pivotal role of calpain-mediated proteolysis in cancer progression, drawing on recent lncRNA research in triple negative breast cancer, and offers actionable guidance for translational researchers. It explores the mechanistic rationale and experimental deployment of Calpain Inhibitor II, ALLM, in apoptosis induction and protease inhibition assays, with a focus on acute lymphoblastic leukemia and lymphoma models. The article differentiates itself by bridging emerging regulatory insights with practical protocol recommendations and strategic guidance for advancing preclinical pipelines.

• Gramine: Advancing Ferroptosis Research in Triple-Negative B

  2026-06-03

  Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) emerges as a precision tool for dissecting ferroptosis and ubiquitination in aggressive breast cancers. This guide details practical workflows, protocol enhancements, and troubleshooting strategies to maximize reproducibility and mechanistic insight using high-purity Gramine from APExBIO.

476 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page